• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Adare Pharma Solutions

    Emergent BioSolutions

    Aphena Pharma Solutions

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Syngene

    Quotient Sciences

    Baxter BioPharma Solutions

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Parenteral Drug Delivery Trends

    A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.

    Parenteral Drug Delivery Trends
    Parenteral Drug Delivery Trends
    Rob Lee, Lubrizol Life Science Health’s CDMO Division President.
    Related CONTENT
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
    • Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    • Recro Pharma Expands Business Development Team
    • LabVantage Solutions Expands and Improves its Portfolio
    Kristin Brooks, Managing Editor, Contract Pharma01.27.21
    The CDMO Division of Lubrizol Life Science Health (LLS Health) is a pharmaceutical contract development and drug product manufacturing organization that offers a range of technical capabilities, multiple technology platforms, and expertise in complex drug delivery.

    LLS Health offers R&D formulation and clinical/commercial drug product manufacturing supported by analytical testing, ICH stability programs, and HPAPI/controlled substance handling. Its technology-agnostic team offers expertise in solubility and bioavailability enhancement, sterile and aseptic manufacturing, and long-acting injectables and implantables.

    Contract Pharma recently caught up with the president of LLS Health, Rob Lee, and talked about the CDMO’s continued growth alongside the rise of biologics and parenteral drug delivery and technology trends in general.

    Contract Pharma (CP): In what services areas are you seeing the most growth?

    Rob Lee (RL): Currently, drug delivery is a significant area of growth, particularly parenteral drug delivery. We have seen a lot of advancement in pre-filled syringes, continuing the trend in healthcare for the past decade towards home healthcare and self-administration of injectables. The rise in insoluble small molecules and biologics is also driving this trend towards parenteral drug delivery.

    At LLS Health, we have seen a lot of interest in companies looking for small batch size commercial manufacturing capacity. This may not be a sweet spot for larger CDMOs who have traditionally designed their manufacturing lines to serve high volume, blockbuster drug products. LLS Health, in contrast, has designed unique manufacturing facilities to accommodate small batch commercial manufacturing and flexible systems to serve the growth of biologics, orphan drug products, and personalized medicine, as well as traditional drug products.

    CP: What are some of the latest technology platforms being leveraged in these service areas?

    RL: Linked to the rise in parenterals, we have seen an increased market interest in more patient centric dosage forms such as infusion-type wearable devices. We have seen growth in highly viscous liquid products that are used in these devices, particularly for biologics, which has led us to re-examine and reconfigure existing technologies that we run in filling operations. These changes meant we had to look at the allotment, filtration, and dosing to retool from an operational and validation standpoint to ensure a consistent product.

    We selected equipment that utilizes tub-filling to accommodate flexible GMP manufacturing.  This technology allows us to fill many different types of primary packaging such as vials, syringes, cartridges, and bottles.

    In addition, there continues to be growing interest in long-acting injectables that can help cut down the number of injections that a patient requires for a given treatment. These are lyophilized products that are reconstituted to form a depot in the body and rely on much of the same expertise as viscous biologic formulations.

    CP: What are the key considerations in designing and executing aseptic processes?

    RL: It is preferable to use closed systems as much as possible. Even when working with an open system and executing manual aseptic processes, it is essential to understand the process and have an experienced, proven engineering team in place to design it and ensure the use of appropriate validation methods to support it. Otherwise the risk of failure due to microbial contamination increases.

    And, of course, aseptic process simulations or media fills must take place prior to an aseptic fill. Media fills involve challenging an aseptic process using a sterile microbiological growth medium to ensure a process prevents contamination during actual production. During a media fill for a new process, the fill is performed three consecutive times to check sterility assurance across the totality of the process, including personnel, equipment, packaging, and manufacturing steps. Any change to an aseptic process may require revalidation, so partnering with a CDMO that has experience and media fill strategy helps ensure aseptic validation does not end up being a drain on project funds and resources.

    CP: What are the main challenges when performing aseptic lyophilization and how can they be overcome?

    RL: A major consideration when dealing with a sterile lyophilized product that is manufactured aseptically is maintaining an ISO 5, Grade A environment for the partially stoppered vials to avoid contamination. This either requires a lyophilizer that is maintained in an ISO 5, Grade A area or the use of isolator technology. At the LLS Health facility, to maintain the greatest amount of flexibility, we have opted to build an ISO 5 Grade A room for our lyophilizer allowing us to incorporate many different technologies. 

    Another challenge centers on formulation considerations related to the continued growth of mixed solvent systems and the use of organics, such as t-butanol. Attempting to remove these solvents and organics during lyophilization poses a challenge, as most lyophilizers are designed to remove water as the primary solvent. To address this challenge, we elected to modify our lyophilizer to include an inline condenser unit to remove the solvent so that the solvent doesn’t liquify in the main condenser or leave the system. 

    CP: What kind of growth are you seeing for aseptic lyophilization for biologics and complex drug products?

    RL: We are seeing significant growth in small batch size complex parenteral drug products, including biologics and nanoparticulate suspensions. The key here is to understand and control the formulation and lyophilization process. 

    For biologics, it is critical to ensure that molecules maintain their three-dimensional structure/conformation and avoid aggregation upon reconstitution. This requires strict control over processing parameters during manufacturing steps such as mixing, filtration, and filling. A well-designed process ensures that large molecule APIs maintain their biological activity and can be properly administered from devices like pre-filled syringes.

    For nanoparticulate suspensions, the key is maintaining the same particle size pre- and post-reconstitution. Developing particulate-based products often requires specialized formulation and analytical techniques to characterize particles and ensure they are unchanged by the lyophilization process. Therefore, it important to work with an organization that has experience in nanoparticulate suspensions and who has worked on many nanomilled products over the years.

    LLS Health has experience working with biologics and nanoparticulate suspensions, giving us access to the formulation techniques, excipients, and characterization tools to specifically address stability and aggregation challenges in a manufacturing setting. For example, a customer who was developing a challenging nanoparticulate-based ophthalmic product approached LLS Health for process optimization and scale-up support. LLS Health’s experience with nanoparticulate suspensions guided formulation development, resulting in a reproducible, highly concentrated, and stable nanoparticulate intermediate. Our team then designed a scaled-up, aseptic manufacturing process and is currently working with the customer to validate the process. This project required LLS Health’s unique nanoparticulate knowledge and our experience with sterile product manufacturing—a rare, but valuable, combination of CDMO services that enabled success. 


    Dr. Rob Lee is president of the CDMO Division of Lubrizol Life Science Health (LLS Health) where he is responsible for product and business development along with providing strategic direction. Before joining LLS Health, Rob held senior management positions at Novavax, Lyotropic Therapeutics and Imcor Pharmaceutical. He has over 30 years of experience in pharmaceutical research and development of both therapeutic drugs and diagnostic imaging agents and has published more than three dozen articles and five book chapters plus holds 11 issued patents and 15 provisional or PCT patent applications. 
    Suggested For You
    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    Recro Pharma Expands Business Development Team Recro Pharma Expands Business Development Team
    LabVantage Solutions Expands and Improves its Portfolio LabVantage Solutions Expands and Improves its Portfolio
    RBQM Comes of Age: COVID as a Catalyst for Change RBQM Comes of Age: COVID as a Catalyst for Change
    Steriline Delivers New Manufacturing Line to Bess Pro Steriline Delivers New Manufacturing Line to Bess Pro
    Vibalogics Updates U.S. Leadership Team Vibalogics Updates U.S. Leadership Team
    Advanced Analytics Advancing Development of Genetic Vaccines Advanced Analytics Advancing Development of Genetic Vaccines
    EMA Approves BioNTech EMA Approves BioNTech's COVID Vax Production at Marburg Site
    CyanVac and Exothera Enter COVID-19 Vaccine Partnership CyanVac and Exothera Enter COVID-19 Vaccine Partnership
    BioCentriq, Kytopen Enter Cell Therapy Alliance BioCentriq, Kytopen Enter Cell Therapy Alliance
    JSR Life Sciences Unveils Corporate Venture Fund JSR Life Sciences Unveils Corporate Venture Fund
    Piramal Pharma Solutions, Plus Therapeutics Ink MSA 
 Piramal Pharma Solutions, Plus Therapeutics Ink MSA 

    BioCentriq and Kytopen Enter Cell Therapy Partnership BioCentriq and Kytopen Enter Cell Therapy Partnership

    Related Features

    • R&D
      Small Innovators & Niche CROs

      Small Innovators & Niche CROs

      Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.
      Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21

    • Laboratory Testing
      Focus on Science

      Focus on Science

      How to maximize lab performance and value through comprehensive equipment management.
      Rohit Shroff, Senior Vice President, Global Lab Products, Avantor 04.01.21

    • Analytical Services | Bioanalytical Services | Laboratory Testing | R&D
      Rapid and Data Rich Chromatographic Method Development

      Rapid and Data Rich Chromatographic Method Development

      An overview of what to consider when developing chromatographic methods.
      Daniel Kirschner, Executive Director of Analytical Services, Cambrex - Durham, North Carolina 04.01.21


    • Preparing Your Post Pandemic Talent Strategy

      Preparing Your Post Pandemic Talent Strategy

      Areas for consideration for adopting the right approach to reinforce investments, optimize business and maximize your workforce.
      Neil Kelly, Managing Partner, Vector Partners 04.01.21

    • Laboratory Testing | R&D
      How Modern Near-Infrared Came to Be

      How Modern Near-Infrared Came to Be

      First region outside the visible to be discovered and last to be utilized.
      Gary E. Ritchie, Contributing Writer 04.01.21

    • APIs | Supply Chain
      Securing Your API Supply Chain: Three Keys to Success

      Securing Your API Supply Chain: Three Keys to Success

      Key considerations when outsourcing API procurement and supply chain management.
      Selwyn Lustman and Lina Cogan, LGM Pharma 04.01.21


    • Solid Dosage/Semi-solids
      Hygienic Packaging Technology

      Hygienic Packaging Technology

      Growing consumer demand for health products highlights hygienic packaging.
      John Brown, Vice President of Global Marketing, Selig 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21


    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Pharmaceutical Manufacturing  Equipment Trends

      Pharmaceutical Manufacturing Equipment Trends

      Demand for flexibility remains the driving force behind equipment systems.
      Kristin Brooks, Managing Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Nutraceutical Manufacturing:  Meeting the Challenges of Today, Planning for  Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • 2021 Contract  Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • APIs
      Small Molecule Development Trends

      Small Molecule Development Trends

      A Q&A with Cambrex Edinburgh’s site director, Mark Benger.
      Tim Wright, Editor, Contract Pharma 03.01.21

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login